PMA P150025S010

Device
PD-L1 IHC 28-8 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150025
Supplement
S010
Product code
PLS
Decision date
2019-01-17
Classification
Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
Implementation of an in-process QC specification.

Current openFDA PMA Record#

Device
PD-L1 IHC 28-8 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150025
Supplement
S010
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2019-01-17
Decision code
OK30
Date received
2018-12-21
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Implementation of an in-process QC specification.